Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuzatrelvir PK Interaction with Carbamazepine in Healthy Adults
NCT06646042Phase 1Completed
- Sponsor
- Pfizer
- Start
- Oct 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ibuzatrelvir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration of Ibuzatrelvir, Area Under the Curve From Time Zero to Extrapolated Infinite Time of Ibuzatrelvir and 1 more. Started Oct 2024; status: completed.
02
Drugs
ibuzatrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06646042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06646042.